← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nob Hill Therapeutics, Inc.
Albuquerque, NM
$4,021,634
Total funding
3
Grants
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,021,634 · 3
By mechanism
R44$3,722,576 · 2
R43$299,058 · 1
Investigators at Nob Hill Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections$1,158,273
R44 · FY2022 · HL
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer$1,138,913
R44 · FY2025 · CA
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer$861,087
R44 · FY2023 · CA
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections$564,303
R44 · FY2023 · HL
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections$299,058
R43 · FY2020 · HL